Pharmaceuticals Segment Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pharmaceuticals Segment stocks.

Pharmaceuticals Segment Stocks Recent News

Date Stock Title
Jul 3 NVO S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3 NVO Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds
Jul 3 NVO Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
Jul 3 NVO Weight-loss drugs linked to rare vision loss: Harvard study
Jul 3 NVO Update: Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
Jul 3 NVO Novo Nordisk’s Ozempic, Wegovy linked to eye disorder in small study
Jul 3 NVO Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
Jul 3 NVO Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
Jul 3 NVO Should You Hold Novo Nordisk A/S (NVO) for the Long Term?
Jul 2 NVO Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices
Jul 2 NVO Biden, Sanders call for obesity drug makers to cut prices
Jul 2 NVO Fighting words: Lilly and Novo swat back at the Biden/Sanders call for lower GLP-1 prices
Jul 2 NVO Update: Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say
Jul 2 NVO Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount
Jul 2 NVO Why Novo Nordisk Stock Is Slipping Today
Jul 2 NVO Novo, Lilly Fall After Biden Slams Duo For 'Unconscionably High' Drug Prices
Jul 2 NVO Eli Lilly history: Beyond the Ticker
Jul 2 NVO Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs
Jul 2 NVO Novo, Lilly Slip as Biden Urges Price Cuts on Obesity Drugs
Jul 2 NVO Big Pharma Stocks Sell Off as Biden Calls for Lower Drug Prices
Pharmaceuticals Segment

Pharmaceuticals segment is a sector of the healthcare industry that focuses on the research, development, production, and marketing of drugs and other pharmaceutical products. This segment includes companies that manufacture and distribute prescription and over-the-counter drugs, as well as those that provide related services such as contract manufacturing and clinical research.

Browse All Tags